Founded Date: 1993-02-01
Technology: Biologics
Investor Type: Company
Funding Status: IPO
Total Funding: 67400000.0
Employee Number: 51-100
Headquarters: Tel Aviv, Tel Aviv, Israel
Last Funding Date: 2021-11-11
Investors Number: 3.0
Last Funding Type: Post-IPO Equity
Estimated Revenue: $10M to $50M
Investment Stage: N/A
Number Of Exists: N/A
Industry: Early Drug Development